Medical technology is advancing at a remarkable pace, yet access and adoption don’t always keep up. Too often, patients, providers, and innovators are limited by outdated pathways that make it harder to connect people with the treatments they need. Those gaps can have profound consequences for patients and their families. When the right connections are made, lives can look very different, a reminder of what’s at stake as MedTech evolves.

In his 2025 keynote, AcuityMD CEO and co-founder Mike Monovoukas will share how artificial intelligence can accelerate the adoption of medical technology. By unlocking smarter development, AI can help ensure that life-changing treatments reach the patients who need them most. He’ll explain why this moment marks a turning point for MedTech, and what it means for the future ahead.

Join us for a fireside chat with endurance athlete, cancer survivor, and managing partner of Next Ventures, Lance Armstrong. Lance will reflect on his early success, his battle with testicular cancer, and the individualized treatment strategy that not only saved his life but reshaped his view of medicine.

This is more than a story of athletic achievement; it’s a testament to resilience, mental endurance, and the transformative power of personalized care. From his foundational work with Livestrong to his current investments in “Whole Person Health,” Lance offers a unique perspective on how innovation in healthcare and the courage to try something new can change lives.

Christian Cuzick, Worldwide President at Johnson & Johnson Neurovascular, will share lessons from a career spent building successful business units, acquiring and integrating innovative startups, and driving transformation across some of the most complex areas of MedTech. Drawing from his leadership roles in orthopedics, cardiovascular, ophthalmology, and neurovascular, Christian will detail how he’s brought together the right people, refined internal processes, and leveraged technology to create more nimble, data-driven commercial organizations.

He'll also discuss how he consistently uses market data to drive his strategic decision making, from understanding procedure trends, to precisely segmenting opportunities, to allocating resources where they’ll have the greatest impact. He’ll also touch on the cultural side of transformation and how he's built systems that are usable, not just available.

Christian's unique leadership perspective on how to use precise insights to drive real change in strategy, execution, and growth will be impactful for all MedTech commercial leaders in attendance.

When bringing a new treatment to market, it’s not enough to know who the patients are. You also need to know where they are located and who influences their treatment journey. Teleflex’s minimally invasive treatment option, the UroLift System, could improve BPH symptoms for millions of patients throughout the United States, but Teleflex needed an efficient and effective way to quickly see the connections between patients, referring providers, and specialists.

This session explores how Teleflex analyzed referral pathways to connect the dots and translate referral data into a multi-pronged GTM strategy, including launching market-specific campaigns, targeted HCP engagement, and aligning their sales resources to the high growth opportunity areas.

Many commercial teams strive to focus sales efforts on high-value accounts—but turning that goal into consistent, field-level execution can be difficult. At Calyxo, the team initially explored a decile-based segmentation model to align rep incentives with opportunity value. But without actionable, consolidated data, prioritization remained manual and inconsistent. 

In this session, learn how Calyxo transformed its targeting strategy by leveraging AcuityMD to centralize insights, streamline account segmentation, and give reps a clear view of where to focus—driving alignment, adoption, and impact in the field.

For growth-stage MedTech companies, preparing for acquisition requires more than a great product. It also requires a clear strategy to generate predictable, recurring revenue.

Mark Wiltshire, former VP of Sales, Artelon, and Rob Brown, Chief Commercial Officer, Bolt Navigation, each led commercial strategies that culminated in successful acquisitions by Stryker and Zimmer Biomet, respectively.

In this session, they’ll share how they accurately sized market opportunity, prioritized the right territories, and created repeatable sales cycles that demonstrated long-term viability and opportunity.

When Profound Medical received CMS reimbursement for TULSA-PRO, they knew they couldn’t rely on old-school sales tactics like relationship selling. 

New Chief Commercial Officer Tom Tamberrino reimagined their launch playbook, using a data-first approach for territory planning, sales enablement, and demonstrating improved clinical and financial outcomes. 

In this session, learn how centering their strategy around detailed market insights unlocked new tactics like hiring reps based on talent - not just experience - aligning them to the highest-value territories, and precisely defining which health systems were - and were not - a perfect fit for their technology.

Selling into IDNs requires more than a compelling pitch. It requires understanding the complex, multi-stakeholder decision process that governs purchasing. 

This panel of IDN experts will share how they evaluate suppliers, what they look for in emerging technology, and how commercial teams can better align with IDN priorities.

Whether you’re at a startup or an established player, you’ll leave knowing how to build stronger partnerships and win more IDN business.

Corza Medical’s Biosurgery team needed precise insight into why they were winning or losing deals, but reps weren’t consistently logging data. This is a common challenge with legacy CRMs because of the high administrative burden they place on reps, but it left Corza leadership with a lack of visibility. 

In this session, Area Sales Directors Kara Dillon and Pat O’Brien will explain how Corza overhauled their sales workflows, removed friction in field reporting, and built real-time dashboards to guide strategic action. 

They’ll also share how Corza partnered closely with AcuityMD as an early adopter of its Forecasting solution, helping shape the product to enable more accurate quotas and real-time visibility into pipeline performance.

The MedTech sales rep role is at an inflection point. In the near future, AI will no longer be a competitive edge, it will be the baseline. Technology will transform reps into highly augmented professionals who spend less time buried in spreadsheets, order forms, and CRM systems, and more time driving successful outcomes. Imagine an AI copilot that dynamically reroutes your day to capture new opportunities, records every meeting and generates instant objection-handling strategies, or smart glasses that livestream complications to guide a surgeon mid-procedure. Administrative burdens, from inventory tracking to compliance paperwork, will fade into the background, handled seamlessly by automation.

Robert Coe, AcuityMD Chief Technology Officer and co-founder, will give a vivid walkthrough of a day in the life of a MedTech rep in 2030, highlighting the performance gap between those who embrace technology and holdouts. Attendees will leave with a clear vision of what winning in MedTech sales will look like in 2030 and spark ideas on how organizations can start preparing today to thrive in this new era.

This roadmap session will share how we’re building for the future. We’ll highlight innovations that connect broader, more complex data sets to surface meaningful insights and drive smarter decisions. You’ll also get a look at upcoming capabilities, from AI exploration to deep product investments, that will shape how teams work and grow their business.